Pricing Log in Create free account

Neumora Therapeutics, Inc. (NMRA) vs VAXART, INC. (VXRT)

Neumora Therapeutics, Inc. and VAXART, INC. are both Biotechnology companies. Neumora Therapeutics, Inc. and VAXART, INC. are of similar size ($92.4M and $91.5M). Neumora Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. has the higher net margin (16.0% vs 0.00%) and the higher return on invested capital (2,542.3% vs 0.00%). Across the 14 metrics below, VAXART, INC. leads on 13 and Neumora Therapeutics, Inc. on 1.

Valuation

Metric NMRA VXRT Biotechnology median
P/E n/m 2.85 10.60
P/S n/m 0.50 9.40
P/B 2.04 1.36 2.13
Price to free cash flow n/m 2.81 25.18
EV/EBITDA n/m 0.56 0.66
EV/Sales n/m 0.14 9.02
Earnings yield (251.02%) 35.14% (32.88%)
Free cash flow yield (198.74%) 35.55% (23.13%)

Profitability

Metric NMRA VXRT Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 16.63% 0.00%
Net margin 0.00% 16.02% 0.00%
Free cash flow margin 0.00% 17.64% 0.00%
Return on equity (187.11%) 62.42% (51.96%)
Return on assets (121.89%) 16.26% (46.06%)
Return on invested capital 0.00% 2,542.26% 0.00%

Growth

Metric NMRA VXRT Biotechnology median
Revenue growth (TTM) — 22.31% 6.76%
EPS growth (last fiscal year) 5.23% 121.21% 29.88%
Revenue growth, 5-year CAGR — 125.76% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NMRA VXRT Biotechnology median
Debt to equity 1.19 0.00 0.00
Current ratio 4.50 1.71 4.97
Net debt to EBITDA 0.53 (2.42) 1.01

Dividend

Metric NMRA VXRT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NMRA VXRT Biotechnology median
Market cap 91.51m 92.41m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack